Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



Labrucherie Gil M Create: Alert

All | News | Filings
Date FiledTypeDescription
10/06/2023 4 Labrucherie Gil M (CFO) has filed a Form 4 on ACELYRIN, Inc.
Txns: Acquired 40,763 shares @ $0
08/21/2023 4 Labrucherie Gil M (CFO) has filed a Form 4 on ACELYRIN, Inc.
Txns: Granted 254,939 options to buy @ $26.94, valued at $6.9M
06/27/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/17/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/06/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/18/2022 4 Labrucherie Gil M (SVP, COO & CFO) has filed a Form 4 on NEKTAR THERAPEUTICS
Txns: Sold 7,579 shares @ $10.95, valued at $83k
12/20/2021 4 Labrucherie Gil M (SVP, COO & CFO) has filed a Form 4 on NEKTAR THERAPEUTICS
Txns: Granted 52,950 shares @ $0
Granted 94,000 options @ $13.22, valued at $1.2M
11/18/2021 4 Labrucherie Gil M (SVP, COO & CFO) has filed a Form 4 on NEKTAR THERAPEUTICS
Txns: Sold 21,149 shares @ $13.16, valued at $278.3k
Sold 3,000 shares @ $12.69, valued at $38.1k
11/17/2021 4 Labrucherie Gil M (SVP, COO & CFO) has filed a Form 4 on NEKTAR THERAPEUTICS
Txns: Granted 40,150 shares @ $0
10/14/2021 4 Labrucherie Gil M (SVP, COO & CFO) has filed a Form 4 on NEKTAR THERAPEUTICS
Txns: Granted 71,550 options to buy @ $21.79, valued at $1.6M
08/18/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/14/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/19/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/18/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/04/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/22/2020 4 Labrucherie Gil M (SVP, COO & CFO) has filed a Form 4 on NEKTAR THERAPEUTICS
Txns: Granted 40,000 shares @ $0
Granted 71,500 options @ $18.75, valued at $1.3M
11/18/2020 4 Labrucherie Gil M (SVP, COO & CFO) has filed a Form 4 on NEKTAR THERAPEUTICS
Txns: Sold 8,276 shares @ $16.93, valued at $140.1k
09/21/2020 4 Labrucherie Gil M (SVP, COO & CFO) has filed a Form 4 on NEKTAR THERAPEUTICS
Txns: Sold 2,000 shares @ $19.96, valued at $39.9k
08/19/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/20/2020 4 Labrucherie Gil M (SVP, COO & CFO) has filed a Form 4 on NEKTAR THERAPEUTICS
Txns: Sold 5,727 shares @ $22.51, valued at $128.9k
Sold 2,000 shares @ $22.62, valued at $45.2k
02/20/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/16/2019 4 Labrucherie Gil M (SVP, COO & CFO) has filed a Form 4 on NEKTAR THERAPEUTICS
Txns: Granted 40,150 shares @ $0
Granted 71,550 options @ $21.79, valued at $1.6M
Granted 29,000 options @ $21.79, valued at $631.9k
11/20/2019 4 Labrucherie Gil M (SVP, COO & CFO) has filed a Form 4 on NEKTAR THERAPEUTICS
Txns: Sold 8,863 shares @ $17.97, valued at $159.3k
11/15/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/17/2019 4 Labrucherie Gil M (SVP, COO & CFO) has filed a Form 4 on NEKTAR THERAPEUTICS
Txns: Sold 25,000 shares @ $15.83, valued at $395.8k
Exercised 25,000 options to buy @ $7.21, valued at $180.3k
10/02/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/18/2019 4 Labrucherie Gil M (SVP & CFO) has filed a Form 4 on NEKTAR THERAPEUTICS
Txns: Sold 25,000 shares @ $20.52, valued at $513k
Exercised 25,000 options to buy @ $7.21, valued at $180.3k
08/27/2019 4 Labrucherie Gil M (SVP & CFO) has filed a Form 4 on NEKTAR THERAPEUTICS
Txns: Exercised 30,000 options @ $16.31, valued at $489.3k
08/19/2019 4 Labrucherie Gil M (SVP & CFO) has filed a Form 4 on NEKTAR THERAPEUTICS
Txns: Sold 5,063 shares @ $18.15, valued at $91.9k
08/16/2019 4 Labrucherie Gil M (SVP & CFO) has filed a Form 4 on NEKTAR THERAPEUTICS
Txns: Sold 25,000 shares @ $17.79, valued at $444.8k
Exercised 25,000 options to buy @ $7.21, valued at $180.3k
07/12/2019 4 Labrucherie Gil M (SVP & CFO) has filed a Form 4 on NEKTAR THERAPEUTICS
Txns: Sold 25,000 shares @ $34.57, valued at $864.3k
Exercised 25,000 options to buy @ $7.21, valued at $180.3k
06/19/2019 4 Labrucherie Gil M (SVP & CFO) has filed a Form 4 on NEKTAR THERAPEUTICS
Txns: Sold 25,000 shares @ $33.71, valued at $842.8k
Exercised 25,000 options to buy @ $7.21, valued at $180.3k
05/17/2019 4 Labrucherie Gil M (SVP & CFO) has filed a Form 4 on NEKTAR THERAPEUTICS
Txns: Sold 3,767 shares @ $31.37, valued at $118.2k
02/21/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy